These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11521990)

  • 1. p21/waf1/cip1 in gastric cancer: associations with histopathological subtypes, lymphonodal metastasis, prognosis and p53 status.
    Baldus SE; Schneider PM; Mönig SP; Zirbes TK; Fromm S; Meyer W; Glossmann J; Schüler S; Thiele J; Hölscher AH; Dienes HP
    Scand J Gastroenterol; 2001 Sep; 36(9):975-80. PubMed ID: 11521990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
    Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
    Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p21 (waf1/cip1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma.
    Gomyo Y; Ikeda M; Osaki M; Tatebe S; Tsujitani S; Ikeguchi M; Kaibara N; Ito H
    Cancer; 1997 Jun; 79(11):2067-72. PubMed ID: 9179052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined examination of p27(Kip1), p21(Waf1/Cip1) and p53 expression allows precise estimation of prognosis in patients with gastric carcinoma.
    Liu XP; Kawauchi S; Oga A; Suehiro Y; Tsushimi K; Tsushimi M; Sasaki K
    Histopathology; 2001 Dec; 39(6):603-10. PubMed ID: 11903579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity.
    Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
    J Pathol; 1996 Oct; 180(2):122-8. PubMed ID: 8976868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer.
    Gamboa-Dominguez A; Seidl S; Reyes-Gutierrez E; Hermannstädter C; Quintanilla-Martinez L; Busch R; Höfler H; Fend F; Luber B
    J Clin Pathol; 2007 Jul; 60(7):756-61. PubMed ID: 17483253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p21 expression in colorectal carcinomas: a study on 103 cases with analysis of p53 gene mutation/expression and clinic-pathological correlations.
    Girlando S; Slomp P; Caffo O; Amichetti M; Togni R; Dvornik G; Tomio L; Galligioni E; Dalla Palma P; Barbareschi M
    Virchows Arch; 1999 Dec; 435(6):559-65. PubMed ID: 10628797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of p53 and p21WAF1/CIP1 proteins in gastric and esophageal cancers: comparison with mutations of the p53 gene.
    Seta T; Imazeki F; Yokosuka O; Saisho H; Suzuki T; Koide Y; Isono K
    Dig Dis Sci; 1998 Feb; 43(2):279-89. PubMed ID: 9512119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p21(WAF1/CIP1) and p53 proteins in gastric carcinoma: its relationships with cell proliferation activity and prognosis.
    Liu XP; Tsushimi K; Tsushimi M; Kawauchi S; Oga A; Furuya T; Sasaki K
    Cancer Lett; 2001 Sep; 170(2):183-9. PubMed ID: 11463497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and p53 tumor suppressor in dysplastic progression and adenocarcinoma in Barrett esophagus.
    Hanas JS; Lerner MR; Lightfoot SA; Raczkowski C; Kastens DJ; Brackett DJ; Postier RG
    Cancer; 1999 Sep; 86(5):756-63. PubMed ID: 10463972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis.
    Pellikainen MJ; Pekola TT; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
    J Clin Pathol; 2003 Mar; 56(3):214-20. PubMed ID: 12610102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p53 and p21 are independent prognostic factors in patients with serosal invasion by gastric carcinoma.
    Ikeguchi M; Saito H; Katano K; Tsujitani S; Maeta M; Kaibara N
    Dig Dis Sci; 1998 May; 43(5):964-70. PubMed ID: 9590408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cell growth by transforming growth factor beta 1 is associated with p53-independent induction of p21 in gastric carcinoma cells.
    Akagi M; Yasui W; Akama Y; Yokozaki H; Tahara H; Haruma K; Kajiyama G; Tahara E
    Jpn J Cancer Res; 1996 Apr; 87(4):377-84. PubMed ID: 8641969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear accumulation of p53 correlates significantly with clinical features and inversely with the expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) in pancreatic cancer.
    Harada N; Gansauge S; Gansauge F; Gause H; Shimoyama S; Imaizumi T; Mattfeld T; Schoenberg MH; Beger HG
    Br J Cancer; 1997; 76(3):299-305. PubMed ID: 9252195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
    Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of p53 and p21(waf1/cip1) immunoreactivity in epithelial cancers of the ovary.
    Werness BA; Freedman AN; Piver MS; Romero-Gutierrez M; Petrow E
    Gynecol Oncol; 1999 Dec; 75(3):413-8. PubMed ID: 10600299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations.
    Viale G; Pellegrini C; Mazzarol G; Maisonneuve P; Silverman ML; Bosari S
    J Pathol; 1999 Feb; 187(3):302-7. PubMed ID: 10398083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas.
    Yook JI; Kim J
    Oral Oncol; 1998 May; 34(3):198-203. PubMed ID: 9692054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of p21/waf1/cip1 in colorectal cancer.
    Zirbes TK; Baldus SE; Moenig SP; Nolden S; Kunze D; Shafizadeh ST; Schneider PM; Thiele J; Hoelscher AH; Dienes HP
    Int J Cancer; 2000 Jan; 89(1):14-8. PubMed ID: 10719725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.